Daniel C Bonis, MD
Pain Management · Long Beach
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 35 years
- University of Southern California Keck School of Medicine, 1991
Offices
3 locations · Medhat F Mikhael MD Inc · Interventional Pain Solutions PC
Looking this up.
Hospitals listed: Enloe Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bonis’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G75707 · Current
Licensed to practise in California · since 1992 · expires 2028-05-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Enloe HealthChico, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Enloe Medical CenterPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.9 (5.5 to 8.6) · 730 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
See every measure and the patient survey for Enloe Health
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.9 (5.5 to 8.6) · 730 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.79 (0.96 to 2.62) · 2,849 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.74 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 203.04 (164.55 to 241.54) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 117 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 377 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 377 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 1,088 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 1,160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 375 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,102 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.05 to 0.39) · 14,875 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.17 (0 to 0.34) · 15,303 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.75 (2.11 to 5.39) · 3,517 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.14 (0.71 to 3.56) · 1,262 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.89 (1.62 to 4.17) · 3,062 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.91 (1.48 to 12.34) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.66 to 7.91) · 1,219 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.04 (0.64 to 3.43) · 643 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.24 to 1.18) · 11,884 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 150 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.739 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.481 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.381 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.344 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 328 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 1,020 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.9 · 400 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.3 · 1,292 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.3 · 1,204 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 1,055 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.4 (10.4 to 14.7) · 730 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 304 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.9 (12.1 to 18.1) · 3,626 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,340 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,476 patients answered, 21% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 57% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$1,050,628
Medicare paid this office $1,050,628 for 500 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 146 | $381,910 | $55 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 146 | $113,976 | $98 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 147 | $104,543 | $30 |
| Return visit (30+ min) | 284 | $57,105 | $95 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 146 | $48,265 | $42 |
See all 44 services
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 146 | $381,910 | $55 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 146 | $113,976 | $98 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 147 | $104,543 | $30 |
| Return visit (30+ min) | 284 | $57,105 | $95 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 146 | $48,265 | $42 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 147 | $44,218 | $38 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 147 | $39,810 | $38 |
| Evaluation of neuropsychological test, first hour | 166 | $34,579 | $97 |
| Evaluation of psychological test, first hour | 167 | $32,429 | $89 |
| Compounded drug, not otherwise classified | 27 | $31,611 | None |
| Insertion of peripheral nerve neurostimulator electrode through skin | 29 | $14,034 | $187 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 168 | $10,012 | $27 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 44 | $9,432 | $210 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 154 | $8,014 | $25 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 60 | $7,673 | $95 |
| Insertion of spinal neurostimulator electrode array through skin | 11 | $7,289 | $235 |
| Short return visit (20+ min) | 71 | $5,952 | $66 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump | 35 | $5,789 | $69 |
| Test or measurement for functional capacity, each 15 minutes | 105 | $5,635 | $22 |
| New patient visit (45+ min) | 44 | $5,175 | $118 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 21 | $4,426 | $201 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 61 | $4,374 | $53 |
| Ultrasonic guidance for needle placement | 38 | $3,891 | $44 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 27 | $3,424 | $101 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 27 | $2,879 | $87 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 43 | $2,738 | $62 |
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 17 | $2,444 | $144 |
| Injection of substance into lower spine canal using imaging guidance | 30 | $2,422 | $73 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 27 | $2,050 | $59 |
| Insertion or replacement of spinal neurostimulator generator or receiver | 13 | $2,007 | $154 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 40 | $1,943 | $46 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 22 | $1,896 | $79 |
| Injection of substance into middle or upper spine canal using imaging guidance | 17 | $1,510 | $79 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 16 | $1,494 | $68 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 18 | $1,418 | $71 |
| Annual depression screening, 5 to 15 minutes | 69 | $1,274 | $18 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 11 | $1,193 | $108 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 98 | $1,107 | $9 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 21 | $959 | $38 |
| Aspiration and/or injection of fluid from large joint | 14 | $548 | $34 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $515 | $40 |
| Fluoroscopic guidance for needle placement | 11 | $237 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $69 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 18 | $21 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 146 | 190 | 161 | 141 | 115 | 81 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 218 | 225 | 225 | 90 | 32 | 44 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 144 | 186 | 160 | 139 | 113 | 83 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 119 | 129 | 130 | 97 | 67 | 45 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 145 | 97 | 141 | 107 | 49 | 33 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 76 | 77 | 104 | 74 | 41 | 25 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
500 Original Medicare patients in 2024. Average age 70 · Under 65 26% · 85 and older 7% · Women 63% · Also on Medicaid 46% · Health risk score 1.68. Above the middle of the specialty; the typical anesthesiology clinician is at 1.54.
Conditions among them: High blood pressure 75% · Depression 51% · Diabetes 35% · COPD 32% · Coronary heart disease 24% · Chronic kidney disease 24% · Atrial fibrillation 19% · Heart failure 16% · Stroke 10% · Cancer 8% · Dementia 8%.
The office billed $3,365,439, Medicare allowed $1,349,864 and paid $1,050,628; for 19,132 services of 78 kinds; $102 of it was for drugs given in the office and $1,050,526 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 500 | 19,132 | 70 | 1.68 | $3,365,439 | $1,050,628 |
| 2023 | 535 | 8,423 | 69 | 1.55 | $1,980,443 | $581,318 |
| 2022 | 763 | 5,619 | 70 | 1.31 | $1,217,875 | $302,912 |
| 2021 | 863 | 10,455 | 69 | 1.43 | $1,967,113 | $493,314 |
| 2020 | 921 | 8,981 | 68 | 1.62 | $2,066,509 | $578,046 |
| 2019 | 1,000 | 12,752 | 68 | 1.46 | $2,258,359 | $708,910 |
| 2018 | 919 | 4,895 | 67 | 1.65 | $1,470,896 | $405,870 |
| 2017 | 1,024 | 4,597 | 69 | 1.70 | $1,244,588 | $328,338 |
| 2016 | 649 | 3,526 | 73 | 1.79 | $877,495 | $231,824 |
| 2015 | 510 | 2,867 | 72 | 1.54 | $754,563 | $192,867 |
| 2014 | 377 | 2,251 | 72 | 1.11 | $454,723 | $144,126 |
| 2013 | 370 | 427 | 71 | 2.36 | $309,062 | $63,883 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 39 services
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 110 | $111,106 | $57 |
| Return visit (30+ min) | 277 | $62,508 | $101 |
| Compounded drug, not otherwise classified | 22 | $60,888 | None |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 110 | $35,083 | $108 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 110 | $31,169 | $32 |
| Evaluation of neuropsychological test, first hour | 130 | $22,322 | $105 |
| Evaluation of psychological test, first hour | 127 | $20,263 | $96 |
| Insertion of spinal neurostimulator electrode array through skin | 28 | $15,674 | $245 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 62 | $14,779 | $221 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 109 | $13,621 | $42 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 110 | $12,898 | $40 |
| Test or measurement for functional capacity, each 15 minutes | 197 | $11,748 | $24 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 110 | $11,321 | $35 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 81 | $10,899 | $95 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 26 | $8,850 | $340 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 35 | $7,807 | $190 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump | 39 | $7,408 | $73 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 42 | $7,112 | $117 |
| Short return visit (20+ min) | 83 | $7,092 | $72 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 130 | $6,110 | $29 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 79 | $6,062 | $54 |
| New patient visit (45+ min) | 46 | $5,717 | $124 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 50 | $5,208 | $85 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 112 | $4,984 | $28 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 39 | $4,359 | $89 |
| Ultrasonic guidance for needle placement | 39 | $4,294 | $46 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 42 | $3,977 | $65 |
| Insertion or replacement of spinal neurostimulator generator or receiver | 21 | $3,744 | $170 |
| Injection of substance into lower spine canal using imaging guidance | 34 | $3,117 | $78 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 59 | $3,105 | $50 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 16 | $2,573 | $151 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 31 | $2,192 | $68 |
| Injection of substance into middle or upper spine canal using imaging guidance | 19 | $1,780 | $81 |
| Aspiration and/or injection of fluid from large joint | 37 | $1,744 | $39 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 34 | $1,697 | $41 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 18 | $1,374 | $76 |
| Annual depression screening, 5 to 15 minutes | 44 | $845 | $19 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $119 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 34 | $46 | None |
2022: 51 services
| Return visit (30+ min) | 317 | $50,667 | $100 |
| Short return visit (20+ min) | 189 | $18,813 | $73 |
| New patient visit (45+ min) | 145 | $18,405 | $127 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 53 | $12,670 | $198 |
| Fusion of pelvic joint using imaging guidance | 18 | $12,009 | $667 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 60 | $11,462 | $166 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 22 | $10,630 | $380 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 31 | $10,589 | $212 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 79 | $10,248 | $102 |
| Insertion of spinal neurostimulator electrode array through skin | 17 | $9,145 | $234 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 30 | $8,300 | $202 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 17 | $7,999 | $222 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 69 | $7,159 | $86 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 43 | $6,243 | $111 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 79 | $5,883 | $59 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 49 | $5,858 | $103 |
| Injection of substance into lower spine canal using imaging guidance | 18 | $4,595 | $209 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 15 | $4,191 | $210 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 28 | $4,129 | $106 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 20 | $3,806 | $159 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 19 | $3,665 | $167 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 21 | $3,592 | $156 |
| Test or measurement for functional capacity, each 15 minutes | 68 | $3,510 | $24 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 42 | $3,455 | $64 |
| Injection of substance into middle or upper spine canal using imaging guidance | 12 | $3,003 | $200 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 22 | $2,623 | $49 |
| Testing for presence of drug, by chemistry analyzers | 42 | $2,610 | $62 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 16 | $2,385 | $92 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 43 | $2,276 | $47 |
| Injection of substance into lower spine canal using imaging guidance | 27 | $2,247 | $75 |
| Insertion or replacement of spinal neurostimulator generator or receiver | 13 | $1,948 | $150 |
| Injection of substance into middle or upper spine canal using imaging guidance | 18 | $1,911 | $87 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 13 | $1,835 | $108 |
| Fluoroscopic guidance for needle placement | 18 | $1,783 | $81 |
| Aspiration and/or injection of fluid from large joint | 32 | $1,731 | $40 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 12 | $1,481 | $114 |
| Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants | 22 | $1,434 | $65 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,124 | $54 |
| Vitamin d-3 level | 27 | $798 | $30 |
| Testing for presence of drug, read by direct observation | 53 | $726 | $13 |
| Injection of trigger points, 3 or more muscles | 16 | $582 | $34 |
| Folic acid level, serum | 27 | $396 | $15 |
| Cyanocobalamin (vitamin b-12) level | 26 | $391 | $15 |
| Blood test, comprehensive group of blood chemicals | 28 | $295 | $11 |
| Magnesium level | 28 | $187 | $7 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 23 | $178 | $8 |
| Injection, dexamethasone sodium phosphate, 1 mg | 127 | $167 | None |
| Phosphate level | 28 | $132 | $5 |
| Uric acid level, blood | 28 | $126 | $5 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $88 | None |
| Insertion of needle into vein for collection of blood sample | 27 | $81 | $3 |
2021: 71 services
| Return visit (30+ min) | 385 | $58,881 | $102 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 142 | $38,158 | $199 |
| Short return visit (20+ min) | 229 | $25,707 | $75 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 56 | $21,618 | $228 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 42 | $21,386 | $411 |
| New patient visit (45+ min) | 161 | $20,875 | $130 |
| Testing for presence of drug, by chemistry analyzers | 210 | $17,982 | $61 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 58 | $15,396 | $197 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 57 | $14,323 | $184 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 41 | $11,600 | $163 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 55 | $10,805 | $157 |
| Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants | 59 | $10,314 | $175 |
| Gene analysis (cytochrome p450 family 3 subfamily a member 4) for common variant | 59 | $10,314 | $175 |
| Gene analysis (cytochrome p450 family 3 subfamily a member 5) for common variant | 59 | $10,314 | $175 |
| Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant | 59 | $10,314 | $175 |
| Insertion of spinal neurostimulator electrode array through skin | 13 | $9,280 | $258 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 71 | $8,292 | $100 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 58 | $8,140 | $104 |
| Molecular pathology procedure level 2 | 59 | $8,083 | $137 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 151 | $7,928 | $51 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 57 | $7,556 | $49 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 12 | $6,601 | $413 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 20 | $5,894 | $218 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 25 | $5,583 | $186 |
| Gene analysis (vitamin k epoxide reductase complex subunit 1) common variants | 59 | $5,204 | $88 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 32 | $5,175 | $89 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 37 | $5,160 | $117 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 38 | $4,804 | $104 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 70 | $4,761 | $58 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 32 | $4,234 | $114 |
| Fluoroscopic guidance for needle placement | 44 | $4,157 | $85 |
| Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants | 59 | $3,855 | $65 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 12 | $3,808 | $181 |
| Injection of substance into middle or upper spine canal using imaging guidance | 14 | $3,611 | $190 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 25 | $3,346 | $56 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 20 | $3,127 | $116 |
| Vitamin d-3 level | 97 | $3,029 | $29 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 37 | $2,889 | $66 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 22 | $2,795 | $108 |
| Aspiration and/or injection of fluid from large joint | 38 | $2,573 | $51 |
| Injection of substance into middle or upper spine canal using imaging guidance | 21 | $2,486 | $86 |
| Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | 11 | $2,343 | $213 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $2,263 | $94 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 35 | $2,189 | $48 |
| Insertion or replacement of spinal neurostimulator generator or receiver | 13 | $2,086 | $160 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 17 | $1,666 | $83 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 25 | $1,617 | $58 |
| Cyanocobalamin (vitamin b-12) level | 96 | $1,513 | $15 |
| New patient visit (30+ min) | 16 | $1,481 | $93 |
| Folic acid level, serum | 96 | $1,475 | $14 |
| Injection of trigger points, 3 or more muscles | 25 | $1,412 | $49 |
| Blood test, comprehensive group of blood chemicals | 101 | $1,136 | $10 |
| Injection of substance into lower spine canal using imaging guidance | 12 | $1,092 | $73 |
| Aspiration and/or injection of fluid from large joint | 20 | $990 | $38 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 12 | $855 | $66 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 90 | $748 | $8 |
| Magnesium level | 101 | $726 | $7 |
| Phosphate level | 101 | $514 | $5 |
| Uric acid level, blood | 100 | $485 | $4 |
| Injection, dexamethasone sodium phosphate, 1 mg | 212 | $328 | None |
| Insertion of needle into vein for collection of blood sample | 100 | $328 | $3 |
| Fluoroscopic guidance for needle placement | 11 | $295 | $23 |
| Ferritin (blood protein) level | 22 | $288 | $13 |
| Cortisol (hormone) measurement, free | 17 | $284 | $17 |
| Creatine kinase (cardiac enzyme) level, total | 32 | $198 | $6 |
| Iron binding capacity | 22 | $185 | $8 |
| Hemoglobin a1c level | 17 | $165 | $10 |
| Iron level | 22 | $137 | $6 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $63 | None |
| Injection, fentanyl citrate, 0.1 mg | 36 | $22 | None |
| Injection, midazolam hydrochloride, per 1 mg | 39 | $9 | None |
2020: 77 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 198 | $55,099 | $197 |
| Short return visit (20+ min) | 357 | $38,337 | $59 |
| Return visit (30+ min) | 313 | $38,301 | $77 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 89 | $26,009 | $200 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 60 | $24,682 | $368 |
| Testing for presence of drug, by chemistry analyzers | 265 | $24,516 | $61 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 57 | $16,084 | $153 |
| Evaluation of neuropsychological test, first hour | 128 | $15,927 | $102 |
| Evaluation of psychological test, first hour | 127 | $14,817 | $97 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 67 | $14,774 | $154 |
| New patient visit (45+ min) | 125 | $14,326 | $115 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 87 | $13,488 | $106 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 46 | $13,314 | $211 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 52 | $11,568 | $187 |
| Molecular pathology procedure level 2 | 91 | $11,298 | $124 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 258 | $10,828 | $30 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 32 | $10,159 | $212 |
| Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants | 48 | $8,391 | $175 |
| Gene analysis (cytochrome p450 family 3 subfamily a member 4) for common variant | 48 | $8,391 | $175 |
| Gene analysis (cytochrome p450 family 3 subfamily a member 5) for common variant | 48 | $8,391 | $175 |
| Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant | 48 | $8,391 | $175 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 17 | $8,046 | $383 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 50 | $6,258 | $104 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 51 | $6,001 | $50 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 17 | $5,961 | $170 |
| New patient visit (30+ min) | 62 | $5,484 | $88 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 32 | $5,220 | $109 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 128 | $5,031 | $32 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 35 | $4,890 | $122 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 34 | $4,760 | $113 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 36 | $4,722 | $107 |
| Vitamin d-3 level | 137 | $4,583 | $29 |
| Gene analysis (vitamin k epoxide reductase complex subunit 1) common variants | 48 | $4,234 | $88 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 18 | $4,159 | $189 |
| Injection of substance into middle or upper spine canal using imaging guidance | 14 | $4,096 | $195 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 31 | $4,072 | $89 |
| Injection of substance into lower spine canal using imaging guidance | 21 | $4,064 | $185 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 29 | $3,664 | $108 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 49 | $3,583 | $61 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 48 | $3,568 | $62 |
| Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants | 48 | $3,136 | $65 |
| Fluoroscopic guidance for needle placement | 30 | $3,096 | $74 |
| Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | 31 | $3,062 | $87 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 17 | $2,713 | $123 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $2,481 | $86 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 18 | $2,454 | $57 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 19 | $2,435 | $106 |
| Cyanocobalamin (vitamin b-12) level | 138 | $2,395 | $15 |
| Folic acid level, serum | 141 | $2,364 | $15 |
| Blood test, comprehensive group of blood chemicals | 144 | $1,772 | $10 |
| Annual depression screening, 5 to 15 minutes | 90 | $1,719 | $19 |
| Aspiration and/or injection of fluid from large joint | 25 | $1,604 | $47 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 25 | $1,485 | $48 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 17 | $1,460 | $70 |
| Injection of substance into middle or upper spine canal using imaging guidance | 11 | $1,350 | $90 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 15 | $1,325 | $70 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 23 | $1,205 | $52 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 129 | $1,165 | $8 |
| Magnesium level | 145 | $1,131 | $7 |
| Injection of substance into lower spine canal using imaging guidance | 12 | $999 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $879 | $59 |
| Aspiration and/or injection of fluid from large joint | 19 | $875 | $40 |
| Phosphate level | 145 | $800 | $5 |
| Uric acid level, blood | 146 | $767 | $4 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 18 | $753 | $42 |
| Ferritin (blood protein) level | 48 | $691 | $13 |
| Creatine kinase (cardiac enzyme) level, total | 81 | $621 | $6 |
| Insertion of needle into vein for collection of blood sample | 145 | $509 | $3 |
| Cortisol (hormone) measurement, free | 28 | $494 | $16 |
| Iron binding capacity | 46 | $418 | $9 |
| Testosterone (hormone) level, total | 13 | $332 | $26 |
| Hemoglobin a1c level | 29 | $318 | $10 |
| Iron level | 43 | $289 | $6 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $148 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 117 | $130 | None |
| Injection, fentanyl citrate, 0.1 mg | 30 | $22 | None |
| Injection, midazolam hydrochloride, per 1 mg | 34 | $7 | None |
2019: 71 services
| Return visit (30+ min) | 656 | $103,181 | $82 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 284 | $79,869 | $194 |
| Evaluation of neuropsychological test, first hour | 212 | $38,700 | $108 |
| Testing for presence of drug, by chemistry analyzers | 382 | $35,805 | $63 |
| Evaluation of psychological test, first hour | 211 | $33,630 | $95 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 64 | $29,663 | $330 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 94 | $28,092 | $228 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 96 | $23,662 | $201 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 62 | $22,912 | $138 |
| New patient visit (45+ min) | 184 | $21,931 | $119 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 109 | $20,564 | $153 |
| Molecular pathology procedure level 2 | 85 | $19,478 | $123 |
| Insertion of spinal neurostimulator electrode array through skin | 11 | $17,701 | $843 |
| Short return visit (20+ min) | 208 | $13,166 | $55 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 94 | $11,894 | $103 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 212 | $11,729 | $33 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 43 | $11,072 | $213 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 26 | $10,435 | $337 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 212 | $10,313 | $29 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 78 | $9,965 | $103 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 25 | $8,792 | $154 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 49 | $8,080 | $144 |
| Insertion of spinal neurostimulator electrode array through skin | 15 | $7,467 | $249 |
| Vitamin d-3 level | 187 | $6,768 | $32 |
| Injection of substance into lower spine canal using imaging guidance | 30 | $6,539 | $198 |
| Injection of substance into middle or upper spine canal using imaging guidance | 28 | $6,301 | $197 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 43 | $5,617 | $108 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 51 | $5,421 | $90 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 24 | $5,292 | $182 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 35 | $4,846 | $110 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 40 | $4,822 | $112 |
| Molecular pathology procedure level 1 | 74 | $4,638 | $63 |
| Fluoroscopic guidance for needle placement | 46 | $4,279 | $69 |
| Measurement of antibody (ige) to allergic substance, crude allergen extract, each | 25 | $4,263 | $6 |
| Destruction of peripheral nerve or branch | 18 | $3,806 | $73 |
| Cyanocobalamin (vitamin b-12) level | 189 | $3,463 | $16 |
| Folic acid level, serum | 188 | $3,362 | $16 |
| Aspiration and/or injection of fluid from large joint | 51 | $2,920 | $45 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 25 | $2,725 | $97 |
| Annual depression screening, 5 to 15 minutes | 141 | $2,658 | $19 |
| Blood test, comprehensive group of blood chemicals | 196 | $2,567 | $12 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 22 | $2,541 | $49 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 19 | $2,290 | $104 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 181 | $1,743 | $8 |
| Magnesium level | 200 | $1,655 | $7 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 25 | $1,621 | $58 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 21 | $1,420 | $59 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $1,282 | $80 |
| New patient visit (30+ min) | 18 | $1,193 | $66 |
| Phosphate level | 198 | $1,161 | $5 |
| Uric acid level, blood | 199 | $1,107 | $5 |
| Injection of substance into lower spine canal using imaging guidance | 12 | $975 | $81 |
| Cortisol (hormone) measurement, free | 40 | $819 | $18 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 13 | $780 | $49 |
| Injection of trigger points, 3 or more muscles | 12 | $700 | $44 |
| Insertion of needle into vein for collection of blood sample | 200 | $667 | $3 |
| Testosterone (hormone) level, total | 22 | $618 | $28 |
| Ferritin (blood protein) level | 36 | $594 | $15 |
| Hemoglobin a1c level | 39 | $465 | $11 |
| Iron level | 42 | $331 | $7 |
| Iron binding capacity | 28 | $276 | $10 |
| Measurement of dna antibody, native or double stranded | 17 | $269 | $15 |
| Measurement of antibody for rheumatoid arthritis assessment | 17 | $254 | $14 |
| Screening test for autoimmune disorder | 17 | $237 | $13 |
| Creatine kinase (cardiac enzyme) level, total | 32 | $227 | $7 |
| Injection, dexamethasone sodium phosphate, 1 mg | 170 | $186 | None |
| Rheumatoid factor level | 17 | $148 | $6 |
| Measurement c-reactive protein for detection of infection or inflammation | 15 | $90 | $6 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 16 | $71 | $4 |
| Injection, fentanyl citrate, 0.1 mg | 39 | $35 | None |
| Injection, midazolam hydrochloride, per 1 mg | 40 | $11 | None |
2018: 64 services
| Short return visit (20+ min) | 392 | $31,742 | $52 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 64 | $27,000 | $342 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 65 | $24,186 | $143 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 86 | $22,576 | $205 |
| Insertion of spinal neurostimulator electrode array through skin | 27 | $17,660 | $252 |
| New patient visit (45+ min) | 140 | $17,118 | $122 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 59 | $16,926 | $217 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 78 | $16,332 | $172 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 30 | $13,403 | $353 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 55 | $13,194 | $227 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 30 | $12,032 | $158 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 82 | $11,568 | $101 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 59 | $11,491 | $195 |
| Return visit (30+ min) | 112 | $10,525 | $84 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 86 | $10,168 | $92 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 51 | $10,046 | $170 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 80 | $9,796 | $48 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 59 | $7,427 | $95 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 52 | $6,259 | $112 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 83 | $6,032 | $52 |
| Injection of substance into middle or upper spine canal using imaging guidance | 27 | $5,777 | $206 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 37 | $5,738 | $110 |
| Testing for presence of drug, by chemistry analyzers | 80 | $5,702 | $70 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 25 | $5,686 | $183 |
| Injection of substance into lower spine canal using imaging guidance | 20 | $5,004 | $200 |
| Measurement of antibody (ige) to allergic substance, crude allergen extract, each | 25 | $4,734 | $6 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 42 | $4,681 | $90 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 48 | $4,459 | $89 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 26 | $3,806 | $55 |
| Insertion or replacement of spinal neurostimulator generator or receiver | 22 | $3,771 | $164 |
| Destruction of peripheral nerve or branch | 16 | $3,710 | $71 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 22 | $3,376 | $153 |
| Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | 25 | $3,372 | $130 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 38 | $3,063 | $58 |
| Molecular pathology procedure level 2 | 12 | $2,940 | $123 |
| Injection of substance into middle or upper spine canal using imaging guidance | 30 | $2,597 | $87 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 48 | $2,448 | $47 |
| Destruction of peripheral nerve or branch | 11 | $2,117 | $47 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 20 | $1,869 | $85 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 18 | $1,827 | $87 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 28 | $1,661 | $52 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 21 | $1,399 | $56 |
| Injection of substance into lower spine canal using imaging guidance | 17 | $1,287 | $71 |
| Vitamin d-3 level | 35 | $1,254 | $36 |
| New patient visit (30+ min) | 13 | $1,131 | $87 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 22 | $1,034 | $33 |
| Molecular pathology procedure level 1 | 13 | $815 | $63 |
| Cyanocobalamin (vitamin b-12) level | 36 | $657 | $18 |
| Aspiration and/or injection of fluid from large joint | 13 | $656 | $47 |
| Folic acid level, serum | 36 | $640 | $18 |
| Blood test, comprehensive group of blood chemicals | 36 | $460 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 35 | $329 | $9 |
| Magnesium level | 37 | $300 | $8 |
| Ferritin (blood protein) level | 17 | $280 | $16 |
| Testing for presence of drug, read by direct observation | 18 | $237 | $13 |
| Phosphate level | 37 | $212 | $6 |
| Uric acid level, blood | 37 | $202 | $5 |
| Iron binding capacity | 17 | $180 | $11 |
| Screening test for autoimmune disorder | 11 | $161 | $15 |
| Iron level | 17 | $133 | $8 |
| Insertion of needle into vein for collection of blood sample | 38 | $112 | $3 |
| Creatine kinase (cardiac enzyme) level, total | 13 | $102 | $8 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 11 | $47 | $4 |
| Injection, dexamethasone sodium phosphate, 1 mg | 16 | $13 | None |
2017: 32 services
| Short return visit (20+ min) | 717 | $98,313 | $55 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 133 | $30,853 | $187 |
| New patient visit (45+ min) | 176 | $22,187 | $126 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 131 | $17,286 | $50 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 140 | $17,100 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 86 | $11,178 | $95 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 138 | $9,903 | $56 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 136 | $9,878 | $56 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 35 | $7,752 | $180 |
| Anesthesia for procedure on gastrointestinal tract using an endoscope | 47 | $6,985 | $143 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 49 | $6,952 | $112 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 19 | $6,794 | $340 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 19 | $5,643 | $141 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 34 | $4,657 | $54 |
| Return visit (30+ min) | 69 | $4,015 | $53 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 39 | $3,869 | $94 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $3,718 | $207 |
| Testing for presence of drug, read by direct observation | 208 | $3,641 | $14 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 45 | $3,615 | $63 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 44 | $3,510 | $64 |
| Injection of substance into middle or upper spine canal using imaging guidance | 29 | $3,249 | $83 |
| Destruction of peripheral nerve or branch | 11 | $2,659 | $47 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 50 | $2,617 | $44 |
| Injection of substance into lower spine canal using imaging guidance | 28 | $2,568 | $73 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 12 | $2,324 | $194 |
| New patient visit (30+ min) | 32 | $2,316 | $72 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 16 | $1,861 | $103 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $1,853 | $103 |
| Aspiration and/or injection of fluid from large joint | 13 | $802 | $53 |
| Aspiration and/or injection of fluid from large joint | 20 | $721 | $33 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 19 | $580 | None |
| X-ray of lower and sacral spine, 2-3 views | 14 | $346 | $25 |
2016: 26 services
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 120 | $32,392 | $220 |
| Short return visit (20+ min) | 324 | $31,717 | $49 |
| Return visit (30+ min) | 197 | $25,649 | $78 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 119 | $18,138 | $59 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 163 | $17,517 | $95 |
| New patient visit (30+ min) | 181 | $12,561 | $69 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 85 | $10,149 | $85 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 163 | $10,112 | $55 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 161 | $10,078 | $55 |
| Anesthesia for procedure on gastrointestinal tract using an endoscope | 45 | $6,810 | $151 |
| Injections of substances into lower or sacral spine | 65 | $5,619 | $65 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 47 | $5,156 | $97 |
| New patient visit (45+ min) | 40 | $4,962 | $124 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 13 | $3,293 | $194 |
| Injections of substances into upper or middle spine | 27 | $3,153 | $83 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 46 | $3,092 | $59 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 46 | $3,024 | $58 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 52 | $2,678 | $39 |
| Injection of trigger points, 3 or more muscles | 27 | $2,115 | $45 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 13 | $1,952 | $59 |
| X-ray of lower and sacral spine, 2-3 views | 82 | $1,940 | $24 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 29 | $1,367 | None |
| Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures, (eg immunoassay) capable of being read by direct optical observation only (eg, dipsticks, cups, cards, cartridges), includes sample validation when performed, per | 93 | $1,208 | $12 |
| Aspiration and/or injection of fluid from large joint | 17 | $827 | $41 |
| Fluoroscopic guidance for needle placement | 17 | $425 | $21 |
| X-ray of upper spine, 2-3 views | 16 | $378 | $24 |
2015: 22 services
| Short return visit (20+ min) | 298 | $37,876 | $52 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 69 | $20,214 | $250 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 143 | $16,615 | $98 |
| New patient visit (30+ min) | 170 | $12,675 | $75 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 69 | $10,667 | $67 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 139 | $9,447 | $57 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 141 | $9,435 | $56 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 56 | $7,435 | $87 |
| Return visit (30+ min) | 59 | $5,986 | $76 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 41 | $5,558 | $105 |
| Injections of substances into lower or sacral spine | 59 | $5,544 | $71 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 41 | $3,162 | $60 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 41 | $3,147 | $61 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 162 | $3,025 | $16 |
| Injections of substances into upper or middle spine | 24 | $2,759 | $86 |
| Anesthesia for procedure on gastrointestinal tract using an endoscope | 16 | $2,545 | $159 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 32 | $1,917 | $41 |
| X-ray of lower and sacral spine, 2-3 views | 49 | $1,196 | $24 |
| Injection of trigger points, 3 or more muscles | 19 | $1,143 | $46 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 26 | $932 | None |
| Fluoroscopic guidance for spine or back muscle injection | 29 | $752 | $25 |
| X-ray of upper spine, 2-3 views | 11 | $247 | $22 |
2014: 19 services
| Short return visit (20+ min) | 220 | $30,995 | $54 |
| New patient visit (30+ min) | 251 | $19,924 | $79 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 129 | $15,004 | $96 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 53 | $13,023 | $237 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 129 | $8,619 | $55 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 120 | $8,015 | $55 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 53 | $6,760 | $64 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 49 | $5,403 | $87 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 37 | $4,916 | $98 |
| Injections of substances into lower or sacral spine | 54 | $4,121 | $55 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 37 | $2,791 | $56 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 35 | $2,551 | $55 |
| Fluoroscopic guidance for spine or back muscle injection | 75 | $2,413 | $24 |
| Return visit (30+ min) | 25 | $2,167 | $77 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 28 | $1,456 | $40 |
| Injections of substances into upper or middle spine | 23 | $1,357 | $57 |
| X-ray of lower and sacral spine, 2-3 views | 45 | $1,144 | $25 |
| Injection of trigger points, 3 or more muscles | 19 | $1,114 | $48 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 15 | $556 | None |
2013: 11 services
| Anesthesia for procedure on gastrointestinal tract using an endoscope | 98 | $14,476 | $142 |
| Anesthesia for nerve block and injection procedure, prone position | 41 | $4,012 | $89 |
| Anesthesia for other procedure on upper abdomen | 13 | $3,776 | $270 |
| Anesthesia for procedure on lower intestine using an endoscope | 25 | $3,506 | $140 |
| Anesthesia for other procedure on skin of arms, legs, and front body | 20 | $2,846 | $142 |
| Anesthesia for other procedure on skin, muscles, or nerves of head, neck, and upper back | 14 | $2,193 | $157 |
| Anesthesia for other procedure on lower leg, ankle, and foot bones | 11 | $2,178 | $182 |
| Anesthesia for other procedure on urinary system through urethra | 18 | $1,939 | $102 |
| Anesthesia for procedure on eye for corneal transplant | 11 | $1,514 | $138 |
| Anesthesia for lens surgery | 14 | $1,439 | $103 |
| Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | 14 | $1,099 | $73 |
Medicaid work
$107,679 in 2024
Medicaid paid $107,679 for 3,152 billed services this clinician did in 2024, up to 70 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Other evaluation and management service | 727 | $46,915 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 456 | $14,468 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure) | 420 | $12,956 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 510 | $12,707 |
| Return visit (30+ min) | 299 | $7,480 |
| Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales, behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes, facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation, and continuity of care with a designated member of the care team. | 356 | $4,031 |
| Neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor) | 14 | $2,197 |
| Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour | 54 | $1,369 |
| New patient visit (45+ min) | 12 | $1,102 |
| Neuropsychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour | 42 | $1,101 |
| Complex chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored, moderate or high complexity medical decision making; first 60 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 71 | $935 |
| Complex chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored, moderate or high complexity medical decision making; each additional 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (List separately in addition to code for primary procedure) | 71 | $918 |
| 2024 | 3,152 | 16 | 70 | $107,679 |
| 2023 | 1,051 | 17 | 38 | $20,046 |
| 2022 | 384 | 5 | 31 | $9,394 |
| 2021 | 1,888 | 17 | 49 | $60,892 |
| 2020 | 2,560 | 25 | 68 | $93,638 |
| 2019 | 5,463 | 28 | 114 | $235,103 |
| 2018 | 704 | 20 | 127 | $56,896 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 264 | $6,019 |
| Neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor) | 17 | $2,371 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure) | 120 | $2,199 |
| Injection procedure for sacroiliac joint, anesthetic/steroid, with image guidance (fluoroscopy or CT) including arthrography when performed | 12 | $2,115 |
| Anesthesia for cesarean delivery only | 14 | $1,806 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level | 13 | $1,547 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 118 | $1,218 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 120 | $936 |
| Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales, behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes, facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation, and continuity of care with a designated member of the care team. | 98 | $454 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; third and any additional level(s) (List separately in addition to code for primary procedure) | 13 | $384 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure) | 13 | $381 |
| Neuropsychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour | 15 | $360 |
2022
| Return visit (30+ min) | 125 | $5,595 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 48 | $2,446 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 65 | $645 |
| Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes | 12 | $584 |
| Injection, dexamethasone sodium phosphate, 1 mg | 134 | $124 |
2021
| Return visit (30+ min) | 440 | $22,095 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 383 | $17,834 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 55 | $8,586 |
| Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes | 106 | $5,834 |
| New patient visit (45+ min) | 32 | $2,651 |
| Fluoroscopic guidance for needle placement (eg, biopsy, aspiration, injection, localization device) (List separately in addition to code for primary procedure) | 36 | $1,217 |
| Arthrocentesis and injection of knee joint | 13 | $380 |
| Measurement of magnesium | 62 | $343 |
| Creatine kinase (CK), (CPK); total | 57 | $324 |
| Injection, dexamethasone sodium phosphate, 1 mg | 451 | $281 |
| COMPREHENSIVE METABOLIC PANEL | 31 | $265 |
| Phosphorus inorganic (phosphate) | 61 | $246 |
2020
| Return visit (30+ min) | 618 | $33,313 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 453 | $21,120 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 101 | $13,096 |
| New patient visit (45+ min) | 67 | $4,904 |
| Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes | 91 | $4,565 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level | 32 | $3,444 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 33 | $3,094 |
| Neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor) | 19 | $2,019 |
| Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure) | 32 | $1,701 |
| GENERAL HEALTH PANEL | 35 | $1,647 |
| Fluoroscopic guidance for needle placement (eg, biopsy, aspiration, injection, localization device) (List separately in addition to code for primary procedure) | 44 | $964 |
| Measurement of magnesium | 133 | $705 |
2019
| Return visit (30+ min) | 965 | $55,038 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 417 | $51,753 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 844 | $34,259 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 147 | $20,141 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 70 | $14,499 |
| GENERAL HEALTH PANEL | 270 | $13,189 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 68 | $10,822 |
| New patient visit (45+ min) | 82 | $5,995 |
| Short return visit (20+ min) | 122 | $5,396 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 31 | $3,239 |
| Measurement of vitamin D 25 hydroxy | 99 | $3,069 |
| Measurement of magnesium | 305 | $1,977 |
2018
| Neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor) | 104 | $22,675 |
| Anesthesia for cesarean delivery only | 61 | $9,041 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 35 | $6,554 |
| Return visit (30+ min) | 129 | $6,147 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 15 | $2,208 |
| Short return visit (20+ min) | 51 | $1,993 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $1,988 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 63 | $1,896 |
| New patient visit (45+ min) | 12 | $1,259 |
| GENERAL HEALTH PANEL | 22 | $1,079 |
| Measurement of vitamin D 25 hydroxy | 15 | $512 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 33 | $456 |
Drugs they prescribed that Part D paid
$67,087
Pharmacies billed $67,087 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 65% of their Part D prescriptions (596 of 922) in 2024. A higher opioid share than 9 in 10 peers; the typical anesthesiology clinician is at 0%. Long-acting opioids: 15% of their opioid prescriptions.
864 generic and 58 brand-name prescriptions · $67,087 in drug cost · 57 antibiotic prescriptions to 50 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 266 | $7,041 | $26 |
| Buprenorphine | 17 | $5,008 | $295 |
| Buprenorphine | 55 | $2,368 | $43 |
| Oxycodone-Acetaminophen | 81 | $1,872 | $23 |
| Oxycodone | 56 | $1,373 | $25 |
See all 16 drugs
| Hydrocodone-Acetaminophen | 266 | $7,041 | $26 |
| Buprenorphine | 17 | $5,008 | $295 |
| Buprenorphine | 55 | $2,368 | $43 |
| Oxycodone-Acetaminophen | 81 | $1,872 | $23 |
| Oxycodone | 56 | $1,373 | $25 |
| Acetaminophen-Codeine | 44 | $1,010 | $23 |
| Morphine Sulfate Er | 25 | $908 | $36 |
| Tizanidine | 18 | $636 | $35 |
| Gabapentin | 45 | $540 | $12 |
| Cyclobenzaprine | 30 | $460 | $15 |
| Tramadol | 53 | $335 | $6 |
| Pregabalin | 17 | $244 | $14 |
| Cephalexin | 50 | $168 | $3 |
| Baclofen | 12 | $155 | $13 |
| Ibuprofen | 14 | $133 | $10 |
| Meloxicam | 14 | $56 | $4 |
Year by year
| 2024 | 922 | 206 | 65% (596) | 6% | $67,087 |
| 2023 | 885 | 195 | 65% (571) | 8% | $94,311 |
| 2022 | 872 | 293 | 54% (470) | 5% | $46,342 |
| 2021 | 1,583 | 448 | 49% (782) | 8% | $105,555 |
| 2020 | 1,945 | 521 | 49% (951) | 7% | $88,767 |
| 2019 | 1,671 | 547 | 49% (818) | 12% | $115,455 |
| 2018 | 900 | 340 | 61% (547) | 11% | $69,134 |
| 2017 | 1,679 | 413 | 78% (1,313) | 9% | $109,895 |
| 2016 | 739 | 170 | 64% (469) | 9% | $41,432 |
| 2015 | 571 | 128 | 64% (363) | 5% | $23,317 |
| 2014 | 292 | 86 | 66% (192) | 9% | $13,994 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Nucynta Er | 14 | $20,124 | $1,437 |
| Treximet | 11 | $14,990 | $1,363 |
| Oxycontin | 17 | $8,829 | $519 |
| Hydrocodone-Acetaminophen | 270 | $7,297 | $27 |
| Fentanyl | 16 | $4,816 | $301 |
| Buprenorphine | 14 | $4,473 | $319 |
| Oxycodone-Acetaminophen | 69 | $2,471 | $36 |
| Buprenorphine | 41 | $2,286 | $56 |
| Oxycodone | 58 | $1,243 | $21 |
| Acetaminophen-Codeine | 42 | $1,046 | $25 |
| Pregabalin | 35 | $1,035 | $30 |
| Buprenorphine-Naloxone | 14 | $820 | $59 |
| Gabapentin | 44 | $815 | $19 |
| Tizanidine | 19 | $798 | $42 |
| Morphine Sulfate Er | 21 | $546 | $26 |
| Tramadol | 33 | $259 | $8 |
| Baclofen | 14 | $227 | $16 |
| Cyclobenzaprine | 15 | $210 | $14 |
| Ibuprofen | 11 | $168 | $15 |
| Cephalexin | 16 | $78 | $5 |
2022: 19 drugs
| Hydrocodone-Acetaminophen | 218 | $4,957 | $23 |
| Buprenorphine | 40 | $2,610 | $65 |
| Oxycodone-Acetaminophen | 60 | $2,538 | $42 |
| Fentanyl | 13 | $2,242 | $172 |
| Gabapentin | 75 | $1,757 | $23 |
| Lidocaine | 15 | $1,690 | $113 |
| Pregabalin | 49 | $1,582 | $32 |
| Buprenorphine-Naloxone | 13 | $1,112 | $86 |
| Morphine Sulfate Er | 28 | $1,008 | $36 |
| Acetaminophen-Codeine | 42 | $793 | $19 |
| Oxycodone | 40 | $666 | $17 |
| Diclofenac | 14 | $551 | $39 |
| Tizanidine | 21 | $489 | $23 |
| Baclofen | 23 | $369 | $16 |
| Tramadol | 32 | $251 | $8 |
| Cephalexin | 31 | $162 | $5 |
| Cyclobenzaprine | 20 | $150 | $7 |
| Methocarbamol | 15 | $110 | $7 |
| Meloxicam | 15 | $70 | $5 |
2021: 24 drugs
| Xtampza Er | 20 | $13,826 | $691 |
| Hydrocodone-Acetaminophen | 340 | $9,165 | $27 |
| Pregabalin | 114 | $4,638 | $41 |
| Oxycontin | 12 | $4,623 | $385 |
| Buprenorphine-Naloxone | 25 | $4,343 | $174 |
| Gabapentin | 167 | $4,223 | $25 |
| Buprenorphine | 78 | $3,416 | $44 |
| Oxycodone-Acetaminophen | 104 | $3,193 | $31 |
| Morphine Sulfate Er | 38 | $1,709 | $45 |
| Fentanyl | 15 | $1,625 | $108 |
| Acetaminophen-Codeine | 46 | $1,412 | $31 |
| Oxycodone | 73 | $1,307 | $18 |
| Lidocaine | 12 | $1,287 | $107 |
| Baclofen | 51 | $1,177 | $23 |
| Diclofenac | 20 | $874 | $44 |
| Cyclobenzaprine | 33 | $792 | $24 |
| Tizanidine | 40 | $439 | $11 |
| Tramadol | 70 | $413 | $6 |
| Methocarbamol | 23 | $301 | $13 |
| Morphine Sulfate | 12 | $295 | $25 |
| Duloxetine | 11 | $266 | $24 |
| Meloxicam | 37 | $179 | $5 |
| Alprazolam | 59 | $154 | $3 |
| Cephalexin | 25 | $143 | $6 |
2020: 27 drugs
| Hydrocodone-Acetaminophen | 404 | $9,248 | $23 |
| Buprenorphine | 28 | $6,705 | $239 |
| Pregabalin | 111 | $6,140 | $55 |
| Buprenorphine | 44 | $4,771 | $108 |
| Gabapentin | 206 | $3,834 | $19 |
| Oxycodone-Acetaminophen | 75 | $3,378 | $45 |
| Diclofenac | 51 | $2,990 | $59 |
| Narcan | 19 | $2,474 | $130 |
| Oxycodone | 100 | $2,131 | $21 |
| Cyclobenzaprine | 53 | $1,959 | $37 |
| Morphine Sulfate Er | 56 | $1,726 | $31 |
| Baclofen | 70 | $1,286 | $18 |
| Acetaminophen-Codeine | 65 | $1,216 | $19 |
| Tizanidine | 43 | $1,116 | $26 |
| Tramadol | 130 | $963 | $7 |
| Morphine Sulfate | 22 | $544 | $25 |
| Nabumetone | 28 | $483 | $17 |
| Sumatriptan | 16 | $370 | $23 |
| Duloxetine | 21 | $288 | $14 |
| Methocarbamol | 19 | $285 | $15 |
| Alprazolam | 123 | $226 | $2 |
| Ibuprofen | 19 | $182 | $10 |
| Cephalexin | 30 | $144 | $5 |
| Meloxicam | 25 | $141 | $6 |
| Amitriptyline | 14 | $140 | $10 |
| Ondansetron | 12 | $113 | $9 |
| Topiramate | 13 | $50 | $4 |
2019: 29 drugs
| Lyrica | 64 | $42,991 | $672 |
| Hydrocodone-Acetaminophen | 360 | $7,538 | $21 |
| Belbuca | 15 | $6,065 | $404 |
| Narcan | 35 | $4,566 | $130 |
| Pregabalin | 54 | $4,391 | $81 |
| Embeda | 11 | $3,777 | $343 |
| Gabapentin | 132 | $2,572 | $19 |
| Diclofenac | 23 | $2,553 | $111 |
| Oxycodone-Acetaminophen | 62 | $2,276 | $37 |
| Oxycodone | 77 | $1,854 | $24 |
| Morphine Sulfate Er | 48 | $1,356 | $28 |
| Fentanyl | 16 | $1,350 | $84 |
| Acetaminophen-Codeine | 62 | $1,185 | $19 |
| Buprenorphine | 14 | $966 | $69 |
| Tizanidine | 42 | $801 | $19 |
| Tramadol | 97 | $761 | $8 |
| Baclofen | 41 | $710 | $17 |
| Cyclobenzaprine | 45 | $671 | $15 |
| Duloxetine | 29 | $621 | $21 |
| Nabumetone | 18 | $470 | $26 |
| Hydrocodone-Ibuprofen | 11 | $381 | $35 |
| Morphine Sulfate | 13 | $333 | $26 |
| Methocarbamol | 15 | $307 | $20 |
| Alprazolam | 124 | $224 | $2 |
| Cephalexin | 37 | $213 | $6 |
| Ibuprofen | 23 | $202 | $9 |
| Amitriptyline | 20 | $173 | $9 |
| Methadone | 13 | $145 | $11 |
| Meloxicam | 22 | $88 | $4 |
2018: 16 drugs
| Lyrica | 37 | $20,580 | $556 |
| Hydrocodone-Acetaminophen | 249 | $5,572 | $22 |
| Buprenorphine | 24 | $3,170 | $132 |
| Fentanyl | 22 | $2,384 | $108 |
| Oxycodone | 74 | $2,126 | $29 |
| Oxycodone-Acetaminophen | 46 | $1,863 | $41 |
| Morphine Sulfate Er | 36 | $1,490 | $41 |
| Gabapentin | 57 | $870 | $15 |
| Methadone | 27 | $449 | $17 |
| Tizanidine | 25 | $347 | $14 |
| Cephalexin | 37 | $270 | $7 |
| Acetaminophen-Codeine | 14 | $221 | $16 |
| Tramadol | 34 | $216 | $6 |
| Ibuprofen | 15 | $176 | $12 |
| Meloxicam | 19 | $94 | $5 |
| Methocarbamol | 12 | $69 | $6 |
2017: 18 drugs
| Oxycontin | 35 | $22,975 | $656 |
| Lyrica | 31 | $14,253 | $460 |
| Hydrocodone-Acetaminophen | 528 | $11,812 | $22 |
| Fentanyl | 63 | $8,753 | $139 |
| Hysingla Er | 11 | $7,646 | $695 |
| Morphine Sulfate Er | 113 | $6,803 | $60 |
| Oxycodone | 220 | $6,059 | $28 |
| Oxycodone-Acetaminophen | 100 | $5,251 | $53 |
| Gabapentin | 85 | $1,207 | $14 |
| Methadone | 67 | $1,098 | $16 |
| Tizanidine | 54 | $943 | $17 |
| Morphine Sulfate | 27 | $660 | $24 |
| Acetaminophen-Codeine | 31 | $563 | $18 |
| Hydromorphone | 19 | $388 | $20 |
| Baclofen | 20 | $217 | $11 |
| Tramadol | 60 | $204 | $3 |
| Meloxicam | 31 | $169 | $5 |
| Diazepam | 14 | $98 | $7 |
2016: 14 drugs
| Oxycontin | 16 | $8,471 | $529 |
| Lyrica | 18 | $8,026 | $446 |
| Hydrocodone-Acetaminophen | 178 | $4,896 | $28 |
| Fentanyl | 40 | $3,330 | $83 |
| Gabapentin | 101 | $1,827 | $18 |
| Oxycodone-Acetaminophen | 45 | $1,800 | $40 |
| Oxycodone | 61 | $1,716 | $28 |
| Morphine Sulfate Er | 24 | $1,306 | $54 |
| Tramadol | 74 | $428 | $6 |
| Morphine Sulfate | 15 | $261 | $17 |
| Methylprednisolone | 15 | $258 | $17 |
| Meloxicam | 30 | $157 | $5 |
| Acetaminophen-Codeine | 12 | $126 | $11 |
| Diazepam | 17 | $55 | $3 |
2015: 10 drugs
| Lyrica | 13 | $6,197 | $477 |
| Hydrocodone-Acetaminophen | 130 | $3,346 | $26 |
| Fentanyl | 35 | $3,307 | $94 |
| Oxycodone-Acetaminophen | 30 | $1,536 | $51 |
| Gabapentin | 91 | $1,455 | $16 |
| Oxycodone | 36 | $972 | $27 |
| Tramadol | 102 | $486 | $5 |
| Methylprednisolone | 18 | $321 | $18 |
| Methocarbamol | 26 | $303 | $12 |
| Meloxicam | 16 | $42 | $3 |
2014: 7 drugs
| Lyrica | 11 | $2,929 | $266 |
| Hydrocodone-Acetaminophen | 88 | $1,917 | $22 |
| Oxycodone-Acetaminophen | 31 | $1,721 | $56 |
| Fentanyl | 13 | $1,508 | $116 |
| Gabapentin | 41 | $1,044 | $25 |
| Methylprednisolone | 12 | $246 | $20 |
| Tramadol | 45 | $234 | $5 |
Money from drug and device companies
$1,091 in 2025
| 2025 | 6 | 44 | None | $1,091 |
| 2024 | 9 | 98 | None | $3,063 |
| 2023 | 7 | 103 | None | $3,522 |
| 2022 | 13 | 131 | None | $4,386 |
| 2021 | 13 | 110 | None | $2,448 |
| 2020 | 7 | 108 | None | $2,442 |
| 2019 | 10 | 119 | None | $2,415 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Proclaim | $730 | 27 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $203 | 10 payments
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $77 | 3 payments
|
| Nalu Medical | Nalu Neurostimulation System | $36 | 2 payments
|
| Spinal Simplicity | Ha Minuteman G3-R | $30 | 1 payment
|
| Medtronic | Synchromedii | $15 | 1 payment
|
See all 44 published payments
| Abbott Laboratories | Meals · 2025-12-31 | Proclaim | $65 |
| Abbott Laboratories | Meals · 2025-12-30 | Proclaim | $7 |
| Boston Scientific | Meals · 2025-12-11 | Wavewriter Alpha Prime 16 | $19 |
| Abbott Laboratories | Meals · 2025-12-08 | Proclaim | $72 |
| Medtronic | Meals · 2025-11-14 | Synchromedii | $15 |
| Boston Scientific | Meals · 2025-11-13 | Wavewriter Alpha Prime 16 | $19 |
| Abbott Laboratories | Meals · 2025-11-10 | Proclaim | $9 |
| Abbott Laboratories | Meals · 2025-11-10 | Proclaim | $13 |
| Nalu Medical | Meals · 2025-10-27 | Nalu Neurostimulation System | $18 |
| Abbott Laboratories | Meals · 2025-10-07 | Proclaim | $49 |
| Curonix | Meals · 2025-10-06 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $21 |
| Abbott Laboratories | Meals · 2025-10-05 | Proclaim | $30 |
| Boston Scientific | Meals · 2025-09-19 | Wavewriter Alpha Prime 16 | $57 |
| Boston Scientific | Meals · 2025-09-12 | Wavewriter Alpha Prime 16 | $35 |
| Abbott Laboratories | Meals · 2025-09-12 | Proclaim | $20 |
| Abbott Laboratories | Meals · 2025-09-11 | Proclaim | $8 |
| Boston Scientific | Meals · 2025-08-15 | General - Pain Management | $24 |
| Abbott Laboratories | Meals · 2025-08-15 | Proclaim | $11 |
| Boston Scientific | Meals · 2025-08-12 | Intracept | $29 |
| Abbott Laboratories | Meals · 2025-08-07 | Proclaim | $66 |
| Abbott Laboratories | Meals · 2025-07-25 | Proclaim | $58 |
| Abbott Laboratories | Meals · 2025-07-09 | Proclaim | $6 |
| Abbott Laboratories | Meals · 2025-06-30 | Proclaim | $42 |
| Nalu Medical | Meals · 2025-06-17 | Nalu Neurostimulation System | $18 |
| Abbott Laboratories | Meals · 2025-06-17 | Proclaim | $7 |
| Abbott Laboratories | Meals · 2025-06-17 | Proclaim | $13 |
| Abbott Laboratories | Meals · 2025-06-06 | Proclaim | $39 |
| Boston Scientific | Meals · 2025-05-27 | Clinical Trial Product | $7 |
| Abbott Laboratories | Meals · 2025-05-09 | Proclaim | $19 |
| Abbott Laboratories | Meals · 2025-05-09 | Proclaim | $22 |
| Abbott Laboratories | Meals · 2025-05-07 | Proclaim | $22 |
| Boston Scientific | Meals · 2025-05-05 | Clinical Trial Product | $8 |
| Abbott Laboratories | Meals · 2025-04-24 | Proclaim | $24 |
| Boston Scientific | Meals · 2025-03-24 | Clinical Trial Product | $2 |
| Abbott Laboratories | Meals · 2025-03-19 | Proclaim | $37 |
| Abbott Laboratories | Meals · 2025-03-19 | Proclaim | $20 |
| Abbott Laboratories | Meals · 2025-03-07 | Proclaim | $10 |
| Spinal Simplicity | Meals · 2025-03-04 | Ha Minuteman G3-R | $30 |
| Boston Scientific | Meals · 2025-02-19 | Clinical Trial Product | $3 |
| Curonix | Meals · 2025-01-21 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $38 |
| Curonix | Meals · 2025-01-20 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $19 |
| Abbott Laboratories | Meals · 2025-01-08 | Proclaim | $10 |
| Abbott Laboratories | Meals · 2025-01-08 | Proclaim | $16 |
| Abbott Laboratories | Meals · 2025-01-08 | Axium | $37 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,063
| Abbott Laboratories | Proclaim | $970 | 38 payments
|
| Nalu Medical | Nalu Neurostimulation System | $877 | 19 payments
|
| Painteq | Painteq | $554 | 10 payments
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $317 | 7 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $228 | 20 payments
|
| Saluda Medical Americas | Evoke | $56 | 1 payment
|
| Vertos Medical | Mild Device Kit | $27 | 1 payment
|
| Si-Bone | None | $19 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $15 | 1 payment
|
2023: $3,522
| Abbott Laboratories | Proclaim | $1,669 | 52 payments
|
| Painteq | Painteq | $537 | 10 payments
|
| Boston Scientific | Infinion 16 | $428 | 18 payments
|
| Relievant Medsystems | Intracept | $388 | 16 payments
|
| Vertos Medical | Mild Device Kit | $356 | 2 payments
|
| Collegium Pharmaceutical | Xtampza | $81 | 4 payments
|
| Saluda Medical Americas | Evoke Scs | $63 | 1 payment
|
2022: $4,386
| Abbott Laboratories | Proclaim | $1,604 | 68 payments
|
| Painteq | Painteq | $1,263 | 30 payments
|
| Relievant Medsystems | Intracept | $858 | 9 payments
|
| Spinal Simplicity | Ha Minuteman G3-R | $400 | 10 payments
|
| Boston Scientific | General - Therapies | $49 | 3 payments
|
| Almatica Pharma | Gralise | $45 | 2 payments
|
| Collegium Pharmaceutical | Xtampza | $40 | 2 payments
|
| Vertos Medical | Mild Device Kit | $34 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $25 | 1 payment
|
| Lundbeck | Vyepti | $24 | 1 payment
|
| GRT US Holding | Qutenza | $16 | 2 payments
|
| Indivior | Sublocade | $14 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $13 | 1 payment
|
2021: $2,448
| Abbott Laboratories | Proclaim Ipg | $1,705 | 80 payments
|
| Painteq | Painteq | $301 | 7 payments
|
| Boston Scientific | Superion | $125 | 7 payments
|
| Medtronic | Synchromed | $72 | 3 payments
|
| Collegium Pharmaceutical | Xtampza | $47 | 3 payments
|
| Pfizer | Reyvow | $42 | 2 payments
|
| BioDelivery Sciences International | Belbuca | $33 | 2 payments
|
| Amgen | Aimovig | $29 | 1 payment
|
| Electronic Waveform Lab | None | $23 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido | $21 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $21 | 1 payment
|
| Lilly USA | Emgality | $17 | 1 payment
|
| AbbVie | Ubrelvy | $14 | 1 payment
|
2020: $2,442
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $2,170 | 99 payments
|
| Foundation Fusion Solutions | None | $139 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido | $46 | 3 payments
|
| Pfizer | Cologuard | $28 | 2 payments
|
| Medtronic USA | Adaptivestim | $24 | 1 payment
|
| Merz North America | Xeomin | $22 | 1 payment
|
| Biodelivery Sciences International | Belbuca | $11 | 1 payment
|
2019: $2,415
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $1,607 | 78 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $292 | 8 payments
|
| Teva Pharmaceuticals USA | Ajovy | $143 | 4 payments
|
| Pfizer | Lyrica | $135 | 15 payments
|
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $57 | 4 payments
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $48 | 3 payments
|
| TerSera Therapeutics | Prialt | $40 | 2 payments
|
| Boston Scientific | Spectra Wavewriter (Refurbished) | $40 | 2 payments
|
| Medtronic USA | Restore | $29 | 2 payments
|
| Ipsen Biopharmaceuticals | Dysport | $25 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 82.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1447261136
- Licence
- CA G75707California G75707: Current · expires 2028-05-31
- Trained
- University of Southern California Keck School of Medicine, 1991 · 35 years ago
- Group
- Medhat F Mikhael MD Inc · Interventional Pain Solutions PC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208VP0000X (208VP0000X); Federal specialty code 207L00000X (207L00000X)
- Mailing address
- 16787 Beach Blvd # 276, Huntington Beach, CA, 92647
- NPI first listed
- 2006-08-10
- NPI last updated
- 2026-01-07
- NPI record certified
- 2026-01-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 16453 Colorado Ave, Paramount, CA, 90723